Garry Redlich

[Garry Redlich @GarryRedlich]

Our ADHF clinical work gets Editors Pick for August in JACC:BTS. Nice work, @AbbateAntonio and team!

[Turan Lab @atgcimmunology]

An amazing review paper by Marco Di Gioia and Ivan Zanoni. A comprehensive and fluent review paper!

[Garry Redlich @GarryRedlich]

@Lo_Zanzi @SciImmunology @MarcoDiGioia Great work

[Ivan Zanoni @Lo_Zanzi]

#DAMPsPower!! Excited to share the 💥new 💥 @SciImmunology review that @marcodigioia & I wrote about the immunological activities played by host-derived oxidized lipids in controlling infections & tumorigenesis! https://t.co/qVdppJmsoB

[Garry Redlich @GarryRedlich]

The FDA granted us a further Fast Track designation for our biologic drug atibuclimab (IC14). ST-elevation myocardial infarction - the dreaded "Widow-Maker" - hits ~250,000 new US cases and ~20,000 in Australia each year. We have this tiger by the tail and intend to tame it!

[Garry Redlich @GarryRedlich]

@AbbateAntonio Re the sentence re zilti not causing a paradoxical increase in IL-6, see Dr Ridker's recent reminder: "all assays for IL-6 measure total IL-6 rather than free IL-6. Thus, after (zilti) total IL-6 levels paradoxically increase as levels of biologically active free IL-6 decline.”

[Garry Redlich @GarryRedlich]

@AbbateAntonio @UVACVRC @Hogwood_AC @randolphcollege He will go far, will Austin. Every good fortune to him.

[Garry Redlich @GarryRedlich]

@AbbateAntonio @MarcoDelBuono3 Absolutely right!

[Garry Redlich @GarryRedlich]

@MarcoDelBuono3 @AbbateAntonio @micheleg1390 Absolutely correct!

[Garry Redlich @GarryRedlich]

@AbbateAntonio @UVACVRC @CardioUva @VCUHealthHeart @bvantassell @micheleg1390 @Hogwood_AC @marchetta97560 We at Implicit Bio could not be happier with your work in making this happen at UVA and UVC! Huge appreciation ...

[Garry Redlich @GarryRedlich]

@micheleg1390 @AbbateAntonio @bvantassell @marchetta97560 @Hogwood_AC You bet!

[Michele Golino @micheleg1390]

A new frontier in #HeartFailure? Proud to contribute to the first-in-patients study of atibuclimab (IC14).
Safe, >95% target, ↓ inflammation, ↓ BNP, ↓ HF symptoms, ↑ LVEF. A promising new strategy!
@AbbateAntonio @bvantassell @GarryRedlich @marchetta97560 @Hogwood_AC

[Matthias Nahrendorf @MatthiasNahrend]

Prolonged Inflammation Associates With Greater Infarct Size and Poor Outcome After ST-Segment Elevation Myocardial Infarction | JACC: Basic to Translational Science https://t.co/TueT5WqJUF

[Immunology Podcast @ImmunoPodcast]

📢 New in @NatImmunol!

Researchers led by Dr. @Lo_Zanzi, including Drs. Kautilya Jena and Pengxiang Qu, have shown that targeting antifungal immune receptors with a mannan-based adjuvant boosts the strength, durability, and variant coverage of #mRNAVaccine responses.

📑: https://t.co/n2ui9mRFeo
🎧: https://t.co/bcu0IQ5eXy

[Garry Redlich @GarryRedlich]

@Lo_Zanzi What a fine looking lab! Power and funding to you all!

[Dr. Marty Makary @DrMakaryFDA]

A milestone day for clinical trial innovation.

We’re announcing the first real-time clinical trials, where @US_FDA can see data signals and endpoints in real time. A quick explainer:

[Garry Redlich @GarryRedlich]

A great review by Doug Mann of a topic close to our heart (and yours, too). In Defense of Homeostasis: Innate Immunity in Cardiac Injury and Repair - Mann - 2026 - Immunological Reviews - Wiley Online Library

[Garry Redlich @GarryRedlich]

Not every day that a friend, colleague and scientific inspiration gets a Chair at Harvard. Well done, Ivan!

[Ivan Zanoni @Lo_Zanzi]

More than thrilled to share that I’ve been promoted to full (tenured) Professor @harvardmed @Harvard. This only happened because of the hard work of many people, but I want to dedicate this promotion to my grandmas, Nonna Maria & Nonna Vevè. A #FirstGen thread 🧵 1/x

[Garry Redlich @GarryRedlich]

@Lo_Zanzi @harvardmed @Harvard What took them so long??
This is great news and your Australian colleagues send their warmest congratulations!

[Garry Redlich @GarryRedlich]

@AbbateAntonio @the_asci Great stuff!